Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-25-106396
Filing Date
2025-11-05
Accepted
2025-11-04 21:24:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0263307-424b5_relmada.htm 424B5 447659
2 GRAPHIC image_001.jpg GRAPHIC 4333
3 GRAPHIC image_002.jpg GRAPHIC 5346
  Complete submission text file 0001213900-25-106396.txt   462385
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-281877 | Film No.: 251451501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)